New drug for cancer
THE US National Cancer Institute plans to test nationwide a drug called taihoxifen that might prevent breast cancer, lower the number of deaths from heart attacks and reduce the number of broken bones among middle-aged and older women. The trial, over a period of five years, will involve about 16,000 women between the ages of 35 and 59, half of who will be given a 20-milligram dose of the drug and the others a placebo.
Tamoxifen has some side effects such as blood clotting and early opause, and uterine cancer in older women. The rug has also been linked to liver cancer in rats.
Related Content
- Order of the High Court of Kerala regarding pricing of breast cancer medicines, 02/11/2023
- WHO report on cancer- setting priorities, investing wisely & providing care for all
- New method for controlled-release makes cancer drugs less toxic to healthy tissues
- Rajasthan health dept to hire for free medicine scheme
- Top drugmakers not doing enough to provide medicines to poor countries: Report
- Fenbendazole acts as a moderate microtubule destabilizing agent and causes cancer cell death by modulating multiple cellular pathways